Quarterly report pursuant to Section 13 or 15(d)

Consolidated Statements of Cash Flows

v3.24.2.u1
Consolidated Statements of Cash Flows - USD ($)
$ in Millions
6 Months Ended
Jun. 30, 2024
Jun. 30, 2023
Cash flows from operating activities    
Net income $ 2,001 $ 8,142
Adjustments to reconcile net income to net cash provided by operating activities:    
Unrealized foreign currency exchange loss (gain), net 3 (2)
Depreciation and amortization expense 606 594
Share-based compensation expense 92 85
Amortization of discount and debt issuance costs 19 23
Reduction of right-of-use assets 330 315
Loss (gain) on modification or extinguishment of debt 9 (18)
Total gains on derivative instruments, net (393) (5,411)
Net cash provided by (used for) settlement of derivative instruments 36 (102)
Deferred taxes 41 1,581
Other, net 8 6
Changes in operating assets and liabilities:    
Trade and other receivables 387 1,249
Inventory 56 418
Margin deposits (88) 98
Accounts payable and accrued liabilities (324) (1,551)
Total deferred revenue (41) (78)
Total operating lease liabilities (324) (305)
Other, net (56) (44)
Net cash provided by operating activities 2,362 5,000
Cash flows from investing activities    
Property, plant and equipment, net (1,153) (1,044)
Investment in equity method investments (12) (18)
Other (20) (6)
Net cash used in investing activities (1,185) (1,068)
Cash flows from financing activities    
Proceeds from issuances of debt 2,725 1,397
Redemptions, repayments and repurchases of debt (3,021) (1,098)
Distributions to non-controlling interest (451) (513)
Payments related to tax withholdings for share-based compensation (41) (56)
Repurchase of common stock (1,699) (774)
Dividends to stockholders (202) (195)
Other, net (57) (14)
Net cash used in financing activities (2,746) (1,253)
Effect of exchange rate changes on cash, cash equivalents and restricted cash and cash equivalents (2) 3
Net increase (decrease) in cash, cash equivalents and restricted cash and cash equivalents (1,571) 2,682
Cash, cash equivalents and restricted cash and cash equivalents—beginning of period 4,525 2,487
Cash, cash equivalents and restricted cash and cash equivalents—end of period $ 2,954 $ 5,169